Pub Date : 2024-12-07DOI: 10.1016/j.amjms.2024.12.006
Jingwei Wang, Zhexia Hu, Zifang Tian, Hui Wu
Purpose: This study aimed to explore the factors influencing the relapse of sputum-positive pulmonary tuberculosis (TB) in elderly patients with diabetes.
Methods: A total of 187 elderly patients with pulmonary tuberculosis (TB) and bacteriological relapse were selected as participants. These patients were divided into two groups: the TB group (82 cases, TB alone) and the combined group (70 cases, TB complicated with diabetes). Additionally, 90 elderly healthy individuals were enrolled in the healthy group. General data, glycosylated hemoglobin (HbA1c), and fasting blood glucose (FBG) levels were collected from all patients, and sputum smears were analyzed.
Results: The combined group exhibited worse outcomes in terms of diabetes duration, lobe cavity, and lesion area compared to the TB group (P < 0.05). Before treatment, the levels of HbA1c and FBG in the combined group were significantly higher than those in the TB group (P < 0.05). After treatment, both groups showed reduced levels of HbA1c and FBG, but the levels remained higher in the combined group compared to the TB group (P < 0.05). Single-factor Logistic regression analysis revealed that the risk factors for TB-positive relapse in diabetes patients complicated with TB included age, diabetes duration, lobe cavity, lesion range, HbA1c, and FBG. Moreover, multivariate Logistic regression analysis identified diabetes duration, lung lobe cavity, lesion area, HbA1c, and FBG as significant risk factors for TB-positive relapse in these patients.
Conclusion: Our study revealed that the risk factors for the relapse of sputum-positive TB in elderly diabetes patients include diabetes duration, lobe cavity, lesion area, HbA1c, and FBG.
{"title":"Influencing factors on relapse of sputum pulmonary tuberculosis in elderly diabetes patients.","authors":"Jingwei Wang, Zhexia Hu, Zifang Tian, Hui Wu","doi":"10.1016/j.amjms.2024.12.006","DOIUrl":"10.1016/j.amjms.2024.12.006","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to explore the factors influencing the relapse of sputum-positive pulmonary tuberculosis (TB) in elderly patients with diabetes.</p><p><strong>Methods: </strong>A total of 187 elderly patients with pulmonary tuberculosis (TB) and bacteriological relapse were selected as participants. These patients were divided into two groups: the TB group (82 cases, TB alone) and the combined group (70 cases, TB complicated with diabetes). Additionally, 90 elderly healthy individuals were enrolled in the healthy group. General data, glycosylated hemoglobin (HbA1c), and fasting blood glucose (FBG) levels were collected from all patients, and sputum smears were analyzed.</p><p><strong>Results: </strong>The combined group exhibited worse outcomes in terms of diabetes duration, lobe cavity, and lesion area compared to the TB group (P < 0.05). Before treatment, the levels of HbA1c and FBG in the combined group were significantly higher than those in the TB group (P < 0.05). After treatment, both groups showed reduced levels of HbA1c and FBG, but the levels remained higher in the combined group compared to the TB group (P < 0.05). Single-factor Logistic regression analysis revealed that the risk factors for TB-positive relapse in diabetes patients complicated with TB included age, diabetes duration, lobe cavity, lesion range, HbA1c, and FBG. Moreover, multivariate Logistic regression analysis identified diabetes duration, lung lobe cavity, lesion area, HbA1c, and FBG as significant risk factors for TB-positive relapse in these patients.</p><p><strong>Conclusion: </strong>Our study revealed that the risk factors for the relapse of sputum-positive TB in elderly diabetes patients include diabetes duration, lobe cavity, lesion area, HbA1c, and FBG.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-06DOI: 10.1016/j.amjms.2024.12.003
Mubashar Karamat, Bansari Patel, Resha Khanal, Mohammad Hamza, Sadaf Fakhra, Ritu Yadav, Neel Navinkumar Patel, Junaid Mir, Nomesh Kumar, Khaled M Harmouch, Masooma Naseem, Yasemin Bahar, Maria Riasat, Harshith Thyagaturu, Yasar Sattar, M Chadi Alraies
Background: This review aims to analyze sex-related differences in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS).
Methods: 10 studies were retrieved from PubMed and Embase comparing outcomes between men and women admitted with AMI complicated by CS. Pooled log odds ratios (OR) were calculated for binary outcomes using the Mantel-Haenszel method, and Hedges' g with the inverse-variance method was used for continuous outcomes.
Results: The primary endpoints were in-hospital mortality and 30-day mortality. The secondary endpoints were reinfarction rate, length of hospital stay (LOS), requirement of renal replacement therapy (RRT), and stroke (ischemic and hemorrhagic). Males exhibited a lower risk of in-hospital mortality (OR 0.77, 95 % CI 0.69-0.85, I2 = 97 %, p < 0.0001), 30-day mortality (OR 0.69, 95 % CI: 0.61-0.78, I² = 0 %, p < 0.0001) and stroke (OR 0.91, 95 % CI 0.87-0.95, I2 = 36 %, p < 0.0001) compared to females. In contrast, males were more likely to require renal replacement therapy (RRT) (OR 1.27, 95 % CI 1.09-1.48, I2 = 69 % p = 0.0017). However, there were no statistically significant differences between females and males in terms of reinfarction rate (OR 0.88, 95 % CI 0.66-1.18, I2 = 56 %, p = 0.3936) or length of hospital stay during hospitalization (Hedges's g 0.35 days, 95 % CI -0.38-1.07, I2 = 100 %, p = 0.34).
Conclusion: Females with AMI and CS have higher in-hospital mortality, 30-day mortality, and stroke risk than men. Men are more likely to require RRT. Further research is needed to understand underlying mechanisms and improve outcomes for both genders.
背景:本综述旨在分析急性心肌梗死(AMI)合并心源性休克(CS)患者的性别差异。方法:从PubMed和Embase检索10项研究,比较AMI合并CS的男性和女性的结局。二元结果采用Mantel-Haenszel方法计算合并对数比值比(OR),连续结果采用Hedges’g和反方差法计算。结果:主要终点为住院死亡率和30天死亡率。次要终点是再梗死率、住院时间(LOS)、肾脏替代治疗(RRT)的需求和卒中(缺血性和出血性)。与女性相比,男性的住院死亡率(OR 0.77, 95% CI 0.69-0.85, I2 = 97%,p < 0.0001)、30天死亡率(OR 0.69, 95% CI: 0.61-0.78, I2 = 0%,p < 0.0001)和中风(OR 0.91, 95% CI 0.87-0.95, I2 = 36%,p < 0.0001)风险较低。相比之下,男性更有可能需要肾脏替代治疗(RRT) (OR 1.27, 95% CI 1.09-1.48, I2 = 69% p = 0.0017)。然而,在再梗死率(OR 0.88, 95% CI 0.66-1.18, I2 = 56%,p = 0.3936)或住院时间(Hedges's g 0.35天,95% CI -0.38-1.07, I2 = 100%,p = 0.34)方面,男女之间无统计学差异。结论:AMI和CS女性的住院死亡率、30天死亡率和卒中风险均高于男性。男性更有可能需要RRT。需要进一步的研究来了解潜在的机制并改善两性的结果。
{"title":"Sex-related differences in patients with acute myocardial infarction complicated by cardiogenic shock: A systematic review and meta-analysis.","authors":"Mubashar Karamat, Bansari Patel, Resha Khanal, Mohammad Hamza, Sadaf Fakhra, Ritu Yadav, Neel Navinkumar Patel, Junaid Mir, Nomesh Kumar, Khaled M Harmouch, Masooma Naseem, Yasemin Bahar, Maria Riasat, Harshith Thyagaturu, Yasar Sattar, M Chadi Alraies","doi":"10.1016/j.amjms.2024.12.003","DOIUrl":"10.1016/j.amjms.2024.12.003","url":null,"abstract":"<p><strong>Background: </strong>This review aims to analyze sex-related differences in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS).</p><p><strong>Methods: </strong>10 studies were retrieved from PubMed and Embase comparing outcomes between men and women admitted with AMI complicated by CS. Pooled log odds ratios (OR) were calculated for binary outcomes using the Mantel-Haenszel method, and Hedges' g with the inverse-variance method was used for continuous outcomes.</p><p><strong>Results: </strong>The primary endpoints were in-hospital mortality and 30-day mortality. The secondary endpoints were reinfarction rate, length of hospital stay (LOS), requirement of renal replacement therapy (RRT), and stroke (ischemic and hemorrhagic). Males exhibited a lower risk of in-hospital mortality (OR 0.77, 95 % CI 0.69-0.85, I<sup>2</sup> = 97 %, p < 0.0001), 30-day mortality (OR 0.69, 95 % CI: 0.61-0.78, I² = 0 %, p < 0.0001) and stroke (OR 0.91, 95 % CI 0.87-0.95, I<sup>2</sup> = 36 %, p < 0.0001) compared to females. In contrast, males were more likely to require renal replacement therapy (RRT) (OR 1.27, 95 % CI 1.09-1.48, I<sup>2</sup> = 69 % p = 0.0017). However, there were no statistically significant differences between females and males in terms of reinfarction rate (OR 0.88, 95 % CI 0.66-1.18, I<sup>2</sup> = 56 %, p = 0.3936) or length of hospital stay during hospitalization (Hedges's g 0.35 days, 95 % CI -0.38-1.07, I<sup>2</sup> = 100 %, p = 0.34).</p><p><strong>Conclusion: </strong>Females with AMI and CS have higher in-hospital mortality, 30-day mortality, and stroke risk than men. Men are more likely to require RRT. Further research is needed to understand underlying mechanisms and improve outcomes for both genders.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-03DOI: 10.1016/j.amjms.2024.12.002
Gianni Turcato, Lucia Filippi, Arian Zaboli, Paolo Ferretto, Daniela Milazzo, Michael Maggi, Francesca Stefani, Marta Parodi, Massimo Marchetti, Christian J Wiedermann
Background: Serum albumin plays a pivotal role in the exchange between interstitial and vascular compartments, and reduced levels of this biomarker appear to be associated with negative prognosis in septic patients. The correlation between the volume effect in sepsis therapy and the kinetics of serum albumin is unclear.
Aim: To investigate the relationship between serum albumin and fluid bolus in relation to its prognostic role in septic patients.
Methods: A single-center prospective observational study conducted from September 2022 to February 2024. All patients with sepsis admitted from the Emergency Department to the Intermediate Medical Care Unit (IMCU) were considered. Post-fluid bolus serum albumin was obtained after fluid bolus. The albumin value was correlated with the volume effect of the fluid bolus, and multivariate models were performed to evaluate its potential independent effect on 30-day mortality.
Results: 179 patients were enrolled. Pre-fluid bolus serum albumin was 2.55 g/dL (SD 0.51) with a multivariate OR for 30-day mortality of 1.170 (95 % CI 1.055-1.297, p = 0.003). After the fluid bolus, which resulted in a fluid balance percentage of +23.1 % (SD 7.1) and a mean Fractional Plasma Dilution of -0.48 (SD 0.18), albumin showed a mean decrease of -0.28 g/dL (SD 0.28) with a multivariate OR for 30-day mortality of 1.198 (95 % CI 1.065-1.348, p = 0.003). Post-fluid bolus albumin was negatively correlated with cumulative fluid balance and hemodilution.
Conclusions: The volume effect of fluid bolus is correlated with a decrease in serum albumin, and low albumin levels are associated with a high risk of mortality.
{"title":"Relationship between fluid bolus administration and the prognostic role of serum albumin in patients with sepsis.","authors":"Gianni Turcato, Lucia Filippi, Arian Zaboli, Paolo Ferretto, Daniela Milazzo, Michael Maggi, Francesca Stefani, Marta Parodi, Massimo Marchetti, Christian J Wiedermann","doi":"10.1016/j.amjms.2024.12.002","DOIUrl":"10.1016/j.amjms.2024.12.002","url":null,"abstract":"<p><strong>Background: </strong>Serum albumin plays a pivotal role in the exchange between interstitial and vascular compartments, and reduced levels of this biomarker appear to be associated with negative prognosis in septic patients. The correlation between the volume effect in sepsis therapy and the kinetics of serum albumin is unclear.</p><p><strong>Aim: </strong>To investigate the relationship between serum albumin and fluid bolus in relation to its prognostic role in septic patients.</p><p><strong>Methods: </strong>A single-center prospective observational study conducted from September 2022 to February 2024. All patients with sepsis admitted from the Emergency Department to the Intermediate Medical Care Unit (IMCU) were considered. Post-fluid bolus serum albumin was obtained after fluid bolus. The albumin value was correlated with the volume effect of the fluid bolus, and multivariate models were performed to evaluate its potential independent effect on 30-day mortality.</p><p><strong>Results: </strong>179 patients were enrolled. Pre-fluid bolus serum albumin was 2.55 g/dL (SD 0.51) with a multivariate OR for 30-day mortality of 1.170 (95 % CI 1.055-1.297, p = 0.003). After the fluid bolus, which resulted in a fluid balance percentage of +23.1 % (SD 7.1) and a mean Fractional Plasma Dilution of -0.48 (SD 0.18), albumin showed a mean decrease of -0.28 g/dL (SD 0.28) with a multivariate OR for 30-day mortality of 1.198 (95 % CI 1.065-1.348, p = 0.003). Post-fluid bolus albumin was negatively correlated with cumulative fluid balance and hemodilution.</p><p><strong>Conclusions: </strong>The volume effect of fluid bolus is correlated with a decrease in serum albumin, and low albumin levels are associated with a high risk of mortality.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142788291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-03DOI: 10.1016/j.amjms.2024.12.004
Renxi Li, Deyanira J Prastein, Brian G Choi
Background: Disparities have been shown in the outcomes of coronary artery bypass grafting (CABG) in racial minorities. Although Native Americans are known to have a higher risk for cardiovascular diseases, the current literature on CABG outcomes for Native Americans remains notably limited, probably due to their limited population size. Thus, this study aimed to investigate racial disparities in CABG outcomes among Native Americans.
Methods: Patients who underwent CABG were identified in National Inpatient Sample database from last quarter of 2015 to 2020. A 1:2 propensity score matching was conducted between Native Americans and Caucasians to address preoperative differences in demographics, socioeconomic status, comorbidity, and hospital characteristics. In-hospital outcomes, length of stay (LOS), time from admission to operation, and total hospital charge were compared.
Results: There were 905 (0.54 %) Native Americans and 125,983 (74.91 %) Caucasians, where 1,838 Caucasians were matched to all the Native Americans. The in-hospital mortality rate was elevated in Native Americans but was not statistically different (2.87 % vs. 2.23 %, p = 0.43). However, Native Americans had a higher risk of cardiogenic shock (8.51 % vs. 6.2 %, p = 0.03). There was no difference in time from admission to operation (2.55 ± 0.11 vs. 2.73 ± 0.08 days, p = 0.20), LOS (9.82 ± 0.23 vs. 9.95 ± 0.20 days, p = 0.65), or the total hospital charge between the two groups (205,594 ± 5192.8 vs. 213,961 ± 4150.9 US dollars, p = 0.20).
Conclusion: Native Americans had a significantly higher risk of cardiogenic shock after CABG. However, in-house mortality and other parameters were not affected. These disparities highlight challenges that Native Americans encounter and emphasize the need for targeted interventions to ensure health equity.
背景:少数种族的冠状动脉旁路移植术(CABG)的结果存在差异。虽然已知美洲原住民患心血管疾病的风险较高,但目前关于美洲原住民冠状动脉搭桥结果的文献仍然非常有限,这可能是由于他们的人口规模有限。因此,本研究旨在调查美洲原住民CABG结果的种族差异。方法:在2015年第四季度至2020年的全国住院患者样本数据库中识别行CABG的患者。在印第安人和白种人之间进行1:2倾向评分匹配,以解决术前人口统计学、社会经济地位、合并症和医院特征的差异。比较住院结果、住院时间(LOS)、入院至手术时间和总住院费用。结果:美洲原住民905人(0.54%),白种人125983人(74.91%),其中白种人与美洲原住民匹配1838人。印第安人的住院死亡率升高,但没有统计学差异(2.87% vs 2.23%, p=0.43)。然而,美洲原住民发生心源性休克的风险更高(8.51% vs 6.2%, p=0.03)。两组患者入院至手术时间(2.55±0.11 vs 2.73±0.08 d, p=0.20)、住院时间(9.82±0.23 vs 9.95±0.20 d, p=0.65)、住院总费用(205,594±5192.8 vs 213,961±4150.9美元,p=0.20)差异均无统计学意义。结论:美洲原住民在CABG后发生心源性休克的风险明显增高。但是,内部死亡率和其他参数没有受到影响。这些差异突出了美洲原住民面临的挑战,并强调需要采取有针对性的干预措施,以确保卫生公平。
{"title":"Racial disparity among Native Americans in coronary artery bypass grafting: An analysis of national inpatient sample from 2015 to 2020.","authors":"Renxi Li, Deyanira J Prastein, Brian G Choi","doi":"10.1016/j.amjms.2024.12.004","DOIUrl":"10.1016/j.amjms.2024.12.004","url":null,"abstract":"<p><strong>Background: </strong>Disparities have been shown in the outcomes of coronary artery bypass grafting (CABG) in racial minorities. Although Native Americans are known to have a higher risk for cardiovascular diseases, the current literature on CABG outcomes for Native Americans remains notably limited, probably due to their limited population size. Thus, this study aimed to investigate racial disparities in CABG outcomes among Native Americans.</p><p><strong>Methods: </strong>Patients who underwent CABG were identified in National Inpatient Sample database from last quarter of 2015 to 2020. A 1:2 propensity score matching was conducted between Native Americans and Caucasians to address preoperative differences in demographics, socioeconomic status, comorbidity, and hospital characteristics. In-hospital outcomes, length of stay (LOS), time from admission to operation, and total hospital charge were compared.</p><p><strong>Results: </strong>There were 905 (0.54 %) Native Americans and 125,983 (74.91 %) Caucasians, where 1,838 Caucasians were matched to all the Native Americans. The in-hospital mortality rate was elevated in Native Americans but was not statistically different (2.87 % vs. 2.23 %, p = 0.43). However, Native Americans had a higher risk of cardiogenic shock (8.51 % vs. 6.2 %, p = 0.03). There was no difference in time from admission to operation (2.55 ± 0.11 vs. 2.73 ± 0.08 days, p = 0.20), LOS (9.82 ± 0.23 vs. 9.95 ± 0.20 days, p = 0.65), or the total hospital charge between the two groups (205,594 ± 5192.8 vs. 213,961 ± 4150.9 US dollars, p = 0.20).</p><p><strong>Conclusion: </strong>Native Americans had a significantly higher risk of cardiogenic shock after CABG. However, in-house mortality and other parameters were not affected. These disparities highlight challenges that Native Americans encounter and emphasize the need for targeted interventions to ensure health equity.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142788290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.amjms.2024.11.008
Fahri Çakan, Adem Adar, Sinan Akıncı, Uğur Köktürk, Ertan Akbay, Orhan Önalan
Background: Metabolic Syndrome (MetS) is an independent risk factor for cardiovascular disease. Perivascular fat depots not only serve as energy storage but also function as endocrine organs. Para-aortic adipose tissue (PAT), a perivascular local adipose tissue, has been suggested to play a role in obesity-mediated vascular disease, and has been associated with MetS components and measures of coronary and abdominal aortic calcification. PAT was previously described and examined using tomography and magnetic resonance imaging. This study aimed to describe the features of para-aortic adipose tissue measured echocardiographically in individuals with MetS.
Methods: Patients were divided into two groups according to their MetS status. The hypoechoic space in front of the ascending aorta was considered a PAT on the parasternal long-axis view. Possible covariates for the regression analysis were determined using the DAGitty diagram.
Results: A total of 494 patients were enrolled in this study. The PAT was significantly higher in the MetS group [9.6 (6.1/10.6) vs. 6.1 (0.9/9) mm, p < 0.001]. Logistic regression analysis revealed that PAT (OR=2,15, p = 0,003) was significantly associated with MetS. 7.55 mm of PAT has a sensitivity of 65 % and specificity of 65 % [AUC = 0.675, p < 0.001, 95 % CI (0.623-0.726)] in predicting the presence of MetS.
Conclusions: Based on the measurements obtained using this newly described modality in transthoracic echocardiography, its relationship with MetS was determined. These results can guide clinicians in diagnosing MetS.
{"title":"Novel predictor for metabolic syndrome: Para-aortic adipose tissue.","authors":"Fahri Çakan, Adem Adar, Sinan Akıncı, Uğur Köktürk, Ertan Akbay, Orhan Önalan","doi":"10.1016/j.amjms.2024.11.008","DOIUrl":"10.1016/j.amjms.2024.11.008","url":null,"abstract":"<p><strong>Background: </strong>Metabolic Syndrome (MetS) is an independent risk factor for cardiovascular disease. Perivascular fat depots not only serve as energy storage but also function as endocrine organs. Para-aortic adipose tissue (PAT), a perivascular local adipose tissue, has been suggested to play a role in obesity-mediated vascular disease, and has been associated with MetS components and measures of coronary and abdominal aortic calcification. PAT was previously described and examined using tomography and magnetic resonance imaging. This study aimed to describe the features of para-aortic adipose tissue measured echocardiographically in individuals with MetS.</p><p><strong>Methods: </strong>Patients were divided into two groups according to their MetS status. The hypoechoic space in front of the ascending aorta was considered a PAT on the parasternal long-axis view. Possible covariates for the regression analysis were determined using the DAGitty diagram.</p><p><strong>Results: </strong>A total of 494 patients were enrolled in this study. The PAT was significantly higher in the MetS group [9.6 (6.1/10.6) vs. 6.1 (0.9/9) mm, p < 0.001]. Logistic regression analysis revealed that PAT (OR=2,15, p = 0,003) was significantly associated with MetS. 7.55 mm of PAT has a sensitivity of 65 % and specificity of 65 % [AUC = 0.675, p < 0.001, 95 % CI (0.623-0.726)] in predicting the presence of MetS.</p><p><strong>Conclusions: </strong>Based on the measurements obtained using this newly described modality in transthoracic echocardiography, its relationship with MetS was determined. These results can guide clinicians in diagnosing MetS.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-30DOI: 10.1016/j.amjms.2024.11.012
Hui Yang, Jinmei Liu, Hongyan Sun
Enteral nutrition is an important clinical nutritional supplementation method, especially for adult patients who are unable to eat normally or require additional nutritional support. However, many patients experience intolerance to enteral nutrition, such as delayed gastric emptying, bloating, and diarrhea, which not only affect the patient's nutritional status but also increase the risk of medical complications. In recent years, medical researchers have been dedicated to identifying and analyzing various factors that contribute to enteral nutrition intolerance, including the patient's disease status, nutritional formula, feeding method, and rate. In addition, research is also exploring the establishment of risk prediction models to more accurately predict which patients may develop enteral nutrition intolerance. These models typically combine clinical parameters, biomarkers, and patient individual characteristics, aiming to assist clinicians in better planning and adjusting nutritional treatment plans, thereby reducing the occurrence of intolerance events. This review summarizes the research progress on enteral nutrition intolerance in adult patients, with a focus on the latest developments in intolerance factors and risk prediction models, providing valuable guidance for clinical practice and helping improve patients' nutritional status and overall health.
{"title":"Risk prediction model for adult intolerance to enteral nutrition feeding - A literature review.","authors":"Hui Yang, Jinmei Liu, Hongyan Sun","doi":"10.1016/j.amjms.2024.11.012","DOIUrl":"10.1016/j.amjms.2024.11.012","url":null,"abstract":"<p><p>Enteral nutrition is an important clinical nutritional supplementation method, especially for adult patients who are unable to eat normally or require additional nutritional support. However, many patients experience intolerance to enteral nutrition, such as delayed gastric emptying, bloating, and diarrhea, which not only affect the patient's nutritional status but also increase the risk of medical complications. In recent years, medical researchers have been dedicated to identifying and analyzing various factors that contribute to enteral nutrition intolerance, including the patient's disease status, nutritional formula, feeding method, and rate. In addition, research is also exploring the establishment of risk prediction models to more accurately predict which patients may develop enteral nutrition intolerance. These models typically combine clinical parameters, biomarkers, and patient individual characteristics, aiming to assist clinicians in better planning and adjusting nutritional treatment plans, thereby reducing the occurrence of intolerance events. This review summarizes the research progress on enteral nutrition intolerance in adult patients, with a focus on the latest developments in intolerance factors and risk prediction models, providing valuable guidance for clinical practice and helping improve patients' nutritional status and overall health.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-28DOI: 10.1016/j.amjms.2024.11.014
Abhinav K Rao, Levi Diggins, Brett Van-Leer Greenberg, James Ravenel, Don C Rockey
A pancreatic fistula is defined as the leakage of pancreatic fluid into another organ or compartment because of pancreatic duct disruption or pseudocyst formation. It is most often seen in middle-aged men between 40 and 50, particularly in patients who have a history of chronic alcoholism and pancreatitis. The tract may fistulae into the pleura, creating a pancreaticopleural fistula, an exceedingly rare condition presenting as a recurrent pleural effusion and extremely high amylase levels, a key distinguishing factor in diagnosis. Here, we present such a case of a recurrent pancreaticopleural fistula and review the presentation, pathophysiology, diagnosis and treatment.
{"title":"Pancreaticopleural fistula: Case report and review of the literature.","authors":"Abhinav K Rao, Levi Diggins, Brett Van-Leer Greenberg, James Ravenel, Don C Rockey","doi":"10.1016/j.amjms.2024.11.014","DOIUrl":"10.1016/j.amjms.2024.11.014","url":null,"abstract":"<p><p>A pancreatic fistula is defined as the leakage of pancreatic fluid into another organ or compartment because of pancreatic duct disruption or pseudocyst formation. It is most often seen in middle-aged men between 40 and 50, particularly in patients who have a history of chronic alcoholism and pancreatitis. The tract may fistulae into the pleura, creating a pancreaticopleural fistula, an exceedingly rare condition presenting as a recurrent pleural effusion and extremely high amylase levels, a key distinguishing factor in diagnosis. Here, we present such a case of a recurrent pancreaticopleural fistula and review the presentation, pathophysiology, diagnosis and treatment.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-28DOI: 10.1016/j.amjms.2024.11.015
Christopher J Peterson, Poornachandran Mohankumar, James A Tarbox, Kenneth Nugent
Alpha-gal syndrome develops in some individuals who have had tick bites which result in IgE responses to alpha-gal, a carbohydrate not found in humans. Patients with alpha-gal syndrome develop symptoms when they ingest mammalian meat, which contains this oligosaccharide. Often the response to this exposure is delayed and occurs 2 to 6 h post-ingestion. Symptoms can include skin rashes, urticaria, gastrointestinal symptoms, and occasionally anaphylaxis. In some patients, the initial site of the skin reaction is at the location of the prior tick bite. The frequency of the syndrome is uncertain but the geographic distribution is predominantly in areas with the lone star tick. The diagnosis depends on careful attention to the time interval between the ingestion of meat and the development of the symptoms. In addition, a history of prior tick bites is important for considering this diagnosis. Diagnostic studies include skin tests, serologic tests for specific IgE, and food challenges, with varying risks for anaphylaxis. The treatment of patients with acute presentations frequently includes intramuscular epinephrine, oral antihistamines, and corticosteroids. Long-term management involves diet modification with the elimination of meat. Patients can also have adverse reactions to medications, such as set cetuximab, heparin, monoclonal antibodies, and pancreatic enzymes, and clinicians will likely have difficulty identifying these reactions. If patients have a good response to diet modification and have a significant reduction in their specific IgE level to alpha-gal, they potentially can resume eating meat in their diet. This should be done under the direction of a specialist.
{"title":"Alpha-Gal Syndrome: A Review for the General Internist.","authors":"Christopher J Peterson, Poornachandran Mohankumar, James A Tarbox, Kenneth Nugent","doi":"10.1016/j.amjms.2024.11.015","DOIUrl":"10.1016/j.amjms.2024.11.015","url":null,"abstract":"<p><p>Alpha-gal syndrome develops in some individuals who have had tick bites which result in IgE responses to alpha-gal, a carbohydrate not found in humans. Patients with alpha-gal syndrome develop symptoms when they ingest mammalian meat, which contains this oligosaccharide. Often the response to this exposure is delayed and occurs 2 to 6 h post-ingestion. Symptoms can include skin rashes, urticaria, gastrointestinal symptoms, and occasionally anaphylaxis. In some patients, the initial site of the skin reaction is at the location of the prior tick bite. The frequency of the syndrome is uncertain but the geographic distribution is predominantly in areas with the lone star tick. The diagnosis depends on careful attention to the time interval between the ingestion of meat and the development of the symptoms. In addition, a history of prior tick bites is important for considering this diagnosis. Diagnostic studies include skin tests, serologic tests for specific IgE, and food challenges, with varying risks for anaphylaxis. The treatment of patients with acute presentations frequently includes intramuscular epinephrine, oral antihistamines, and corticosteroids. Long-term management involves diet modification with the elimination of meat. Patients can also have adverse reactions to medications, such as set cetuximab, heparin, monoclonal antibodies, and pancreatic enzymes, and clinicians will likely have difficulty identifying these reactions. If patients have a good response to diet modification and have a significant reduction in their specific IgE level to alpha-gal, they potentially can resume eating meat in their diet. This should be done under the direction of a specialist.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-27DOI: 10.1016/j.amjms.2024.11.009
Jun Wan, Feng Xu, Chunlin Yin, Yang Jiang, Cai Chen, Yulin Wang, Heping Zuo, Jinglin Cheng, He Li
Background: Hypoxia-inducible factor-1α (HIF-1α) has an essential role in ventricular remodeling processes involving myocardial fibrosis and hypertrophy, but the clinical significance of HIF-1α levels in the early period after ST-segment elevation myocardial infarction (STEMI) for the prediction of left ventricular remodeling (LVR) has yet to be fully elucidated.
Objective: To investigate the predictive value of HIF-1α for LVR after STEMI based on the echocardiographic parameters.
Methods: In this prospective observational study, plasma samples were collected within 12 hours of onset from 183 patients with a first reperfused anterior ST-segment elevation myocardial infarction (STEMI), and HIF-1α levels were measured using enzyme-linked immunosorbent assay (ELISA). At baseline and 12 months after discharge, all patients underwent repeat echocardiography. The changes of echocardiography parameters from baseline to 12 months were used to reflect the changes of ventricular structure and function. An increase in end-diastolic volume of ≥20% was defined as LVR.
Results: The levels of HIF-1α were highly correlated with the changes of echocardiography parameters (ΔLVEF, ΔLVEDD, as well as ΔLVEDV). During the follow-up period, patients with higher HIF-1α concentrations had higher incidence of LVR, poorer ventricular function, and a lower MACE-free survival. Multivariate analysis showed the single-point HIF-1α was an independent predictor of LVR (odds ratio[OR]: 4.813; 95% CI: 1.553 to 14.918; P = 0.006). The HIF-1α levels predicted LVR with an AUC of 0.7905 (95% CI: 0.7067 to 0.8744; P < 0.0001). The combination of HIF-1α and N-terminal probrain natriuretic peptide (NT-proBNP) yielded a favorable increase in AUC to 0.8121 (95% CI: 0.7345 to 0.8896; P < 0.0001).
Conclusion: These results demonstrate that serum HIF-1α levels can predict LVR after STEMI independently.
{"title":"Predictive value of HIF-1α for left ventricular remodeling following an anterior ST-segment elevation myocardial infarction.","authors":"Jun Wan, Feng Xu, Chunlin Yin, Yang Jiang, Cai Chen, Yulin Wang, Heping Zuo, Jinglin Cheng, He Li","doi":"10.1016/j.amjms.2024.11.009","DOIUrl":"10.1016/j.amjms.2024.11.009","url":null,"abstract":"<p><strong>Background: </strong>Hypoxia-inducible factor-1α (HIF-1α) has an essential role in ventricular remodeling processes involving myocardial fibrosis and hypertrophy, but the clinical significance of HIF-1α levels in the early period after ST-segment elevation myocardial infarction (STEMI) for the prediction of left ventricular remodeling (LVR) has yet to be fully elucidated.</p><p><strong>Objective: </strong>To investigate the predictive value of HIF-1α for LVR after STEMI based on the echocardiographic parameters.</p><p><strong>Methods: </strong>In this prospective observational study, plasma samples were collected within 12 hours of onset from 183 patients with a first reperfused anterior ST-segment elevation myocardial infarction (STEMI), and HIF-1α levels were measured using enzyme-linked immunosorbent assay (ELISA). At baseline and 12 months after discharge, all patients underwent repeat echocardiography. The changes of echocardiography parameters from baseline to 12 months were used to reflect the changes of ventricular structure and function. An increase in end-diastolic volume of ≥20% was defined as LVR.</p><p><strong>Results: </strong>The levels of HIF-1α were highly correlated with the changes of echocardiography parameters (ΔLVEF, ΔLVEDD, as well as ΔLVEDV). During the follow-up period, patients with higher HIF-1α concentrations had higher incidence of LVR, poorer ventricular function, and a lower MACE-free survival. Multivariate analysis showed the single-point HIF-1α was an independent predictor of LVR (odds ratio[OR]: 4.813; 95% CI: 1.553 to 14.918; P = 0.006). The HIF-1α levels predicted LVR with an AUC of 0.7905 (95% CI: 0.7067 to 0.8744; P < 0.0001). The combination of HIF-1α and N-terminal probrain natriuretic peptide (NT-proBNP) yielded a favorable increase in AUC to 0.8121 (95% CI: 0.7345 to 0.8896; P < 0.0001).</p><p><strong>Conclusion: </strong>These results demonstrate that serum HIF-1α levels can predict LVR after STEMI independently.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-26DOI: 10.1016/j.amjms.2024.11.011
Yan-Yan Li, Hui Wang, Yang-Yang Zhang
Objective: Methionine synthetase (MS) A2756G and Cystathionine-β-synthase (CBS) 844ins68 gene polymorphisms were indicated to be associated with increased coronary artery disease (CAD) risk. Nevertheless, because the results of each experiment are different, there is no consensus till now. This meta-analysis aimed to clarify the relationship between MS gene A2756G and CBS gene 844ins68 polymorphisms and CAD.
Methods: 11,555 participants from 24 individual studies, 2162 participants from 6 individual studies were included in the MS gene A2756G and CBS 844ins68 gene polymorphisms meta-analysis respectively. To determine whether MS gene A2756G or CBS gene 844ins68 polymorphism was associated with CAD risk, a random or fixed-effect genetic model was adopted using pooled odds ratios (ORs) and their corresponding 95 % confidence intervals (CIs).
Results: MS gene A2756G polymorphism was significantly associated with CAD under recessive (OR: 1.400, 95 % CI: 1.119-1.751, P = 0.003) and homozygous genetic models (OR: 1.360, 95 % CI: 1.084-1.706, P = 0.008). In the African subgroup, the association was significant under the allelic, recessive, dominant, heterozygous, homozygous and additive (P < 0.05) genetic models. In the Asian subgroup, the association was significant under the allelic, recessive and homozygous genetic models (P < 0.05). No significant association was found between CBS 844ins68 gene polymorphism and CAD under all of the genetic models (P > 0.05).
Conclusions: MS gene A2756G polymorphism was significantly associated with increased CAD risk, especially in the African and Asian population. The G allele carriers of MS gene A2756G polymorphism were more susceptible to be suffered from CAD disease than others.
{"title":"Methionine synthetase A2756G and Cystathionine-β-synthase 844ins68 polymorphisms and coronary artery disease: A meta-analysis.","authors":"Yan-Yan Li, Hui Wang, Yang-Yang Zhang","doi":"10.1016/j.amjms.2024.11.011","DOIUrl":"10.1016/j.amjms.2024.11.011","url":null,"abstract":"<p><strong>Objective: </strong>Methionine synthetase (MS) A2756G and Cystathionine-β-synthase (CBS) 844ins68 gene polymorphisms were indicated to be associated with increased coronary artery disease (CAD) risk. Nevertheless, because the results of each experiment are different, there is no consensus till now. This meta-analysis aimed to clarify the relationship between MS gene A2756G and CBS gene 844ins68 polymorphisms and CAD.</p><p><strong>Methods: </strong>11,555 participants from 24 individual studies, 2162 participants from 6 individual studies were included in the MS gene A2756G and CBS 844ins68 gene polymorphisms meta-analysis respectively. To determine whether MS gene A2756G or CBS gene 844ins68 polymorphism was associated with CAD risk, a random or fixed-effect genetic model was adopted using pooled odds ratios (ORs) and their corresponding 95 % confidence intervals (CIs).</p><p><strong>Results: </strong>MS gene A2756G polymorphism was significantly associated with CAD under recessive (OR: 1.400, 95 % CI: 1.119-1.751, P = 0.003) and homozygous genetic models (OR: 1.360, 95 % CI: 1.084-1.706, P = 0.008). In the African subgroup, the association was significant under the allelic, recessive, dominant, heterozygous, homozygous and additive (P < 0.05) genetic models. In the Asian subgroup, the association was significant under the allelic, recessive and homozygous genetic models (P < 0.05). No significant association was found between CBS 844ins68 gene polymorphism and CAD under all of the genetic models (P > 0.05).</p><p><strong>Conclusions: </strong>MS gene A2756G polymorphism was significantly associated with increased CAD risk, especially in the African and Asian population. The G allele carriers of MS gene A2756G polymorphism were more susceptible to be suffered from CAD disease than others.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}